Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical study of apatinib mesylate tablets combined with chemotherapy in the treatment of platinum sensitive recurrent ovarian cancer

Next Previous
Trial Profile

Clinical study of apatinib mesylate tablets combined with chemotherapy in the treatment of platinum sensitive recurrent ovarian cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Apr 2018

At a glance

  • Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Rivoceranib (Primary)
  • Indications Ovarian cancer
  • Focus Therapeutic Use

    • Most Recent Events

    • 05 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top